Form 8-K - Current report:
SEC Accession No. 0001193125-23-036914
Filing Date
2023-02-14
Accepted
2023-02-14 06:12:16
Documents
39
Period of Report
2023-02-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d430763d8k.htm   iXBRL 8-K 26962
2 EX-99.1 d430763dex991.htm EX-99.1 32791
6 GRAPHIC g430763ex99_1s10g1.jpg GRAPHIC 432536
7 GRAPHIC g430763ex99_1s11g1.jpg GRAPHIC 451145
8 GRAPHIC g430763ex99_1s12g1.jpg GRAPHIC 436534
9 GRAPHIC g430763ex99_1s13g1.jpg GRAPHIC 297841
10 GRAPHIC g430763ex99_1s14g1.jpg GRAPHIC 337162
11 GRAPHIC g430763ex99_1s15g1.jpg GRAPHIC 597874
12 GRAPHIC g430763ex99_1s16g1.jpg GRAPHIC 350898
13 GRAPHIC g430763ex99_1s17g1.jpg GRAPHIC 303577
14 GRAPHIC g430763ex99_1s18g1.jpg GRAPHIC 394231
15 GRAPHIC g430763ex99_1s19g1.jpg GRAPHIC 300851
16 GRAPHIC g430763ex99_1s1g1.jpg GRAPHIC 500195
17 GRAPHIC g430763ex99_1s20g1.jpg GRAPHIC 335371
18 GRAPHIC g430763ex99_1s21g1.jpg GRAPHIC 430589
19 GRAPHIC g430763ex99_1s22g1.jpg GRAPHIC 226854
20 GRAPHIC g430763ex99_1s23g1.jpg GRAPHIC 315583
21 GRAPHIC g430763ex99_1s24g1.jpg GRAPHIC 251327
22 GRAPHIC g430763ex99_1s25g1.jpg GRAPHIC 348420
23 GRAPHIC g430763ex99_1s26g1.jpg GRAPHIC 304883
24 GRAPHIC g430763ex99_1s2g1.jpg GRAPHIC 468978
25 GRAPHIC g430763ex99_1s3g1.jpg GRAPHIC 418525
26 GRAPHIC g430763ex99_1s4g1.jpg GRAPHIC 483402
27 GRAPHIC g430763ex99_1s5g1.jpg GRAPHIC 362001
28 GRAPHIC g430763ex99_1s6g1.jpg GRAPHIC 419523
29 GRAPHIC g430763ex99_1s7g1.jpg GRAPHIC 400160
30 GRAPHIC g430763ex99_1s8g1.jpg GRAPHIC 426253
31 GRAPHIC g430763ex99_1s9g1.jpg GRAPHIC 497495
  Complete submission text file 0001193125-23-036914.txt   14103285

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA spry-20230214.xsd EX-101.SCH 2853
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE spry-20230214_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spry-20230214_pre.xml EX-101.PRE 11709
33 EXTRACTED XBRL INSTANCE DOCUMENT d430763d8k_htm.xml XML 3474
Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Filer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39756 | Film No.: 23621877
SIC: 2834 Pharmaceutical Preparations